|
|
Latest Stem Cell Transplant News
Complementary Therapy for Children Undergoing Stem Cell Transplant (7/19/2010)
Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer.
Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (3/24/2010)
Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology.
Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants (10/27/2008)
Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (8/12/2008)
The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet Oncology.
Statins May Reduce Acute Graft-versus-host Disease (6/18/2008)
Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants. These results were reported at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, May 30-June 2.
Stem Cell Transplant News By Topic
Stem Cell Transplant - Autologous Stem Cell TransplantComplementary Therapy for Children Undergoing Stem Cell Transplant (7/19/2010)
Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer.
Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (3/24/2010)
Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology.
Stem Cell Transplant Procedures Vary Throughout the World (5/9/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas). These findings were published in the Journal of Clinical Oncology.
MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma (2/1/2007)
According to results recently published in Annals of Oncology, the chemotherapy regimen consisting of melphalan, chlorambucil, and prednisone (MCP) appears to interfere with the ability to collect enough stem cells for an autologous stem cell transplant in patients with follicular non-Hodgkin’s lymphoma (NHL).
At-home Stem Cell Transplantation Reduces Cost and Hospital Time (10/26/2006)
According to an article recently published in the Journal of Clinical Oncology, at-home treatment for an autologous stem cell transplant reduces medical cost and hospital stay among patients with hematologic (blood) malignancies.
Stem Cell Transplant - Allogeneic Stem Cell TransplantComplementary Therapy for Children Undergoing Stem Cell Transplant (7/19/2010)
Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer.
Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants (10/27/2008)
Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (8/12/2008)
The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet Oncology.
Statins May Reduce Acute Graft-versus-host Disease (6/18/2008)
Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants. These results were reported at the 2008 annual meeting of the American Society of Clinical Oncology in Chicago, May 30-June 2.
Stem Cell Transplant Procedures Vary Throughout the World (5/9/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas). These findings were published in the Journal of Clinical Oncology.
|
|
